fda compounding semaglutide warning september 2025 warns telehealth providers over obesity drug marketing Patients struggle as compounded GLP-1

Build your financial planning and expectations around this reality

These medications are FDA-approved specifically for type 2 diabetes management or chronic weight loss, requiring prescriptions after medical evaluation and administered via weekly or daily injections

But GLP-1 is not synthetic by nature it is physiological

Healthcare providers must educate patients on the correct administration technique to ensure optimal efficacy and safety

Most of it resolves as the dose titrates

Some patients are prescribed metformin as an adjunct to GLP-1 therapy for metabolic reasons insulin resistance, prediabetes, or PMOS